Insulet Corporation Acquires Assets of Automated Glucose Control LLC (AGC)

February 14, 2023

Insulet Corporation acquired the assets and license portfolio of Automated Glucose Control LLC (AGC), a Palo Alto–based developer of automated insulin delivery technology. The asset purchase (approx. $25 million) transfers AGC’s UC Santa Barbara–licensed intellectual property and related technology to Insulet to accelerate development of its Omnipod automated insulin delivery systems.

Buyers
Insulet Corporation
Targets
Automated Glucose Control LLC (AGC)
Sellers
Automated Glucose Control LLC (AGC)
Industry
Medical Devices
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.